ACEA Biosciences Overview
- Founded
- 2002

- Status
- Acquired/Merged
- Employees
- 201

- Latest Deal Type
- M&A
- Latest Deal Amount
- $250M

ACEA Biosciences General Information
Description
Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. The company's instruments use microelectrodes in automated high-throughput plate formats to offer real time cell analysis, enabling doctors to monitor cell proliferation, cell size, cell-substrate attachment quality and cell invasion easily.
Contact Information
- 6779 Mesa Ridge Road
- Suite 100
- San Diego, CA 92121
- United States
ACEA Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 14-Nov-2018 | $250M | 000.00 | 00000 | Completed | Generating Revenue |
6. Later Stage VC (Series E) | 01-Apr-2016 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
5. Grant | 03-Jul-2013 | 000.00 | Completed | Generating Revenue | ||
4. Later Stage VC (Series D) | 10-Sep-2007 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
3. Later Stage VC (Series C) | 00.000 | 00.00 | 000.00 | Completed | Generating Revenue | |
2. Early Stage VC (Series B) | $1.85M | $4.15M | 000.00 | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | $2.3M | $2.3M | 00.000 | Completed | Generating Revenue |
ACEA Biosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series E | 0,000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Series D | 0,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 0.000 |
Series C | 0,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Series B | 1,589,690 | $0.001000 | 4% | $1.16 | $1.16 | 1x | $1.16 | 7.98% |
Series A | 3,199,414 | $0.001000 | 4% | $0.95 | $0.95 | 1x | $0.95 | 16.06% |
ACEA Biosciences Comparisons
Industry
000000 0
00000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialACEA Biosciences Competitors (25)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Active Motif | Corporate Backed or Acquired | Carlsbad, CA | 00 | 000000000000 | ||
00000 | Formerly VC-backed | Fremont, CA | 000 | 00000 | 00000000 | 00000 |
000000 00000000 | Venture Capital-Backed | Cambridge, United Kingdom | 00 | 000.00 | 0000000000 0 | 000.00 |
00000 0000000 0000 | Formerly VC-backed | San Diego, CA | 00 | 000.00 | 00000000000 | 000.00 |
0000000000 | Venture Capital-Backed | South San Francisco, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
ACEA Biosciences Patents
ACEA Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3662281-A4 | Cell-substrate impedance monitoring of cancer cells of different lineage, origin, or stage | Pending | 01-Aug-2017 | 00000000000 | 0 |
EP-3662281-A1 | Cell-substrate impedance monitoring of cancer cells of different lineage, origin, or stage | Pending | 01-Aug-2017 | 00000000000 | |
US-20210364494-A1 | Cell-substrate impedance monitoring of cancer cells of different lineage, origin, or stage | Pending | 01-Aug-2017 | 00000000000 | |
US-20200071672-A1 | Methods and systems for functional maturation of ipsc and esc derived cardiomyocytes | Pending | 03-Mar-2017 | 000000000 | |
EP-3589299-A1 | Methods and systems for functional maturation of ipsc and esc derived cardiomyocytes | Pending | 03-Mar-2017 | C12N5/0657 |
ACEA Biosciences Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialACEA Biosciences Former Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Lilly Asia Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Qiming Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
U.S. Environmental Protection Agency | Government | 000 0000 | 000000 0 |